These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 27323783)
21. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. Haorah J; Ramirez SH; Schall K; Smith D; Pandya R; Persidsky Y J Neurochem; 2007 Apr; 101(2):566-76. PubMed ID: 17250680 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases and ADAMs in stroke. Montaner J; Ramiro L; Simats A; Hernández-Guillamon M; Delgado P; Bustamante A; Rosell A Cell Mol Life Sci; 2019 Aug; 76(16):3117-3140. PubMed ID: 31165904 [TBL] [Abstract][Full Text] [Related]
23. [Matrix metaloproteinases in neurological brain lesions: a new therapeutic target?]. Vilalta A; Sahuquillo Barris J; Poca MA Rev Neurol; 2010 Jul; 51(2):95-107. PubMed ID: 20602315 [TBL] [Abstract][Full Text] [Related]
24. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Muri L; Leppert D; Grandgirard D; Leib SL Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218 [TBL] [Abstract][Full Text] [Related]
25. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis. Boziki M; Grigoriadis N Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases in vascular physiology and disease. Siefert SA; Sarkar R Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663 [TBL] [Abstract][Full Text] [Related]
27. Interplays Between Matrix Metalloproteinases and Neurotropic Viruses: An Overview. Alghamdi SA; Alissa M; Alghamdi A; Alshehri MA; Albelasi A; Alzahrani KJ; Safhi AY Rev Med Virol; 2024 Nov; 34(6):e2585. PubMed ID: 39349731 [TBL] [Abstract][Full Text] [Related]
29. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases]. Hamacher S; Matern S; Roeb E Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740 [TBL] [Abstract][Full Text] [Related]
30. The many faces of EMMPRIN - roles in neuroinflammation. Agrawal SM; Yong VW Biochim Biophys Acta; 2011 Feb; 1812(2):213-9. PubMed ID: 20674741 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the blood-brain barrier integrity by pericytes via matrix metalloproteinases mediated activation of vascular endothelial growth factor in vitro. Thanabalasundaram G; Pieper C; Lischper M; Galla HJ Brain Res; 2010 Aug; 1347():1-10. PubMed ID: 20553880 [TBL] [Abstract][Full Text] [Related]
34. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura. Mannello F Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213 [TBL] [Abstract][Full Text] [Related]
35. Evidence implicating matrix metalloproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Russo R; Siviglia E; Gliozzi M; Amantea D; Paoletti A; Berliocchi L; Bagetta G; Corasaniti MT Int Rev Neurobiol; 2007; 82():407-21. PubMed ID: 17678975 [TBL] [Abstract][Full Text] [Related]
36. Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development. Bronisz E; Kurkowska-Jastrzębska I Mediators Inflamm; 2016; 2016():7369020. PubMed ID: 28104930 [TBL] [Abstract][Full Text] [Related]
37. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Lee JY; Kim HS; Choi HY; Oh TH; Yune TY Brain; 2012 Aug; 135(Pt 8):2375-89. PubMed ID: 22798270 [TBL] [Abstract][Full Text] [Related]
38. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. Mroczko B; Groblewska M; Barcikowska M J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694 [TBL] [Abstract][Full Text] [Related]
39. Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders. Bañuelos-Cabrera I; Valle-Dorado MG; Aldana BI; Orozco-Suárez SA; Rocha L Arch Med Res; 2014 Nov; 45(8):677-86. PubMed ID: 25446620 [TBL] [Abstract][Full Text] [Related]
40. Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke. Zhang Y; Fan F; Zeng G; Zhou L; Zhang Y; Zhang J; Jiao H; Zhang T; Su D; Yang C; Wang X; Xiao K; Li H; Zhong Z J Cereb Blood Flow Metab; 2017 Aug; 37(8):2963-2974. PubMed ID: 27885100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]